Targeting hypoxia to improve non–small cell lung cancer outcome
A Salem, MC Asselin, B Reymen… - JNCI: Journal of the …, 2018 - academic.oup.com
Oxygen deprivation (hypoxia) in non–small cell lung cancer (NSCLC) is an important factor
in treatment resistance and poor survival. Hypoxia is an attractive therapeutic target …
in treatment resistance and poor survival. Hypoxia is an attractive therapeutic target …
Mechanism-based modeling of tumor growth and treatment response constrained by multiparametric imaging data
Multiparametric imaging is a critical tool in the noninvasive study and assessment of cancer.
Imaging methods have evolved over the past several decades to provide quantitative …
Imaging methods have evolved over the past several decades to provide quantitative …
Overcoming hypoxia-restrained radiotherapy using an erythrocyte-inspired and glucose-activatable platform
H Huang, C Zhang, X Wang, J Shao, C Chen, H Li… - Nano Letters, 2020 - ACS Publications
Radiotherapy (RT) as one of the most powerful cancer treatment strategies has been greatly
restricted by tumor hypoxia. A mounting effort has been devoted to develop oxygen delivery …
restricted by tumor hypoxia. A mounting effort has been devoted to develop oxygen delivery …
18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to …
KM Reeves, PN Song, A Angermeier, DD Manna… - Clinical Cancer …, 2022 - AACR
Purpose: Hypoxia is a common characteristic of many tumor microenvironments, and it has
been shown to promote suppression of antitumor immunity. Despite strong biological …
been shown to promote suppression of antitumor immunity. Despite strong biological …
Quantifying tumor heterogeneity via MRI habitats to characterize microenvironmental alterations in HER2+ breast cancer
AS Kazerouni, DA Hormuth, T Davis, MJ Bloom… - Cancers, 2022 - mdpi.com
Simple Summary Tumor heterogeneity influences tumor progression and response to
therapy, introducing a significant challenge in the treatment of breast cancer. We employed …
therapy, introducing a significant challenge in the treatment of breast cancer. We employed …
Multiparametric analysis of longitudinal quantitative MRI data to identify distinct tumor habitats in preclinical models of breast cancer
This study identifies physiological tumor habitats from quantitative magnetic resonance
imaging (MRI) data and evaluates their alterations in response to therapy. Two models of …
imaging (MRI) data and evaluates their alterations in response to therapy. Two models of …
Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+ breast cancer
AM Jarrett, MJ Bloom, W Godfrey… - … and biology: a …, 2019 - academic.oup.com
The goal of this study is to develop an integrated, mathematical–experimental approach for
understanding the interactions between the immune system and the effects of trastuzumab …
understanding the interactions between the immune system and the effects of trastuzumab …
Preclinical PET imaging of granzyme B shows promotion of immunological response following combination paclitaxel and immune checkpoint inhibition in triple …
TS Napier, CL Hunter, PN Song, BM Larimer… - Pharmaceutics, 2022 - mdpi.com
Advancements in monitoring and predicting of patient-specific response of triple negative
breast cancer (TNBC) to immunotherapy (IMT) with and without chemotherapy are needed …
breast cancer (TNBC) to immunotherapy (IMT) with and without chemotherapy are needed …
Integrating metabolic reprogramming and metabolic imaging to predict breast cancer therapeutic responses
Y Liu, Q Zhou, S Song, S Tang - Trends in Endocrinology & Metabolism, 2021 - cell.com
Metabolic reprogramming is not only an emerging hallmark of cancer, but also an essential
regulator of cancer cell adaptation to the microenvironment. Metabolic imaging targeting …
regulator of cancer cell adaptation to the microenvironment. Metabolic imaging targeting …
[HTML][HTML] Characterizing trastuzumab-induced alterations in intratumoral heterogeneity with quantitative imaging and immunohistochemistry in HER2+ breast cancer
The purpose of this study is to investigate imaging and histology-based measurements of
intratumoral heterogeneity to evaluate early treatment response to targeted therapy in a …
intratumoral heterogeneity to evaluate early treatment response to targeted therapy in a …